| Product Code: ETC10600687 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of human insulin drugs and delivery devices to Israel in 2024 were primarily sourced from top exporting countries including Switzerland, USA, Germany, China, and Belgium. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained very high, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 experienced a significant decline of -13.88%, but there was a notable growth rate of 8.63% from 2023 to 2024, suggesting a potential rebound in the market. Israel continues to be a key destination for these essential healthcare products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Human Insulin Drugs and Delivery Devices Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Human Insulin Drugs and Delivery Devices Market - Industry Life Cycle |
3.4 Israel Human Insulin Drugs and Delivery Devices Market - Porter's Five Forces |
3.5 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Insulin Type, 2021 & 2031F |
3.6 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Delivery Device, 2021 & 2031F |
3.7 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.8 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Patient Demographic, 2021 & 2031F |
3.9 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Treatment Goal, 2021 & 2031F |
4 Israel Human Insulin Drugs and Delivery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Human Insulin Drugs and Delivery Devices Market Trends |
6 Israel Human Insulin Drugs and Delivery Devices Market, By Types |
6.1 Israel Human Insulin Drugs and Delivery Devices Market, By Insulin Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Type, 2021 - 2031F |
6.1.3 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Rapid-Acting Insulin, 2021 - 2031F |
6.1.4 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Long-Acting Insulin, 2021 - 2031F |
6.1.5 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Pre-mixed Insulin, 2021 - 2031F |
6.1.6 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Glargine, 2021 - 2031F |
6.2 Israel Human Insulin Drugs and Delivery Devices Market, By Delivery Device |
6.2.1 Overview and Analysis |
6.2.2 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pens, 2021 - 2031F |
6.2.3 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pumps, 2021 - 2031F |
6.2.4 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Syringes, 2021 - 2031F |
6.2.5 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pumps/Pens, 2021 - 2031F |
6.3 Israel Human Insulin Drugs and Delivery Devices Market, By Formulation Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.3 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.5 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4 Israel Human Insulin Drugs and Delivery Devices Market, By Patient Demographic |
6.4.1 Overview and Analysis |
6.4.2 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Type 1 Diabetes, 2021 - 2031F |
6.4.3 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.4.4 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Children, Adults, 2021 - 2031F |
6.4.5 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Elderly Population, 2021 - 2031F |
6.5 Israel Human Insulin Drugs and Delivery Devices Market, By Treatment Goal |
6.5.1 Overview and Analysis |
6.5.2 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Blood Sugar Control, 2021 - 2031F |
6.5.3 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Long-term Glycemic Control, 2021 - 2031F |
6.5.4 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Immediate Blood Sugar Regulation, 2021 - 2031F |
6.5.5 Israel Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Overnight Glucose Control, 2021 - 2031F |
7 Israel Human Insulin Drugs and Delivery Devices Market Import-Export Trade Statistics |
7.1 Israel Human Insulin Drugs and Delivery Devices Market Export to Major Countries |
7.2 Israel Human Insulin Drugs and Delivery Devices Market Imports from Major Countries |
8 Israel Human Insulin Drugs and Delivery Devices Market Key Performance Indicators |
9 Israel Human Insulin Drugs and Delivery Devices Market - Opportunity Assessment |
9.1 Israel Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Insulin Type, 2021 & 2031F |
9.2 Israel Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Delivery Device, 2021 & 2031F |
9.3 Israel Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.4 Israel Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Patient Demographic, 2021 & 2031F |
9.5 Israel Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Treatment Goal, 2021 & 2031F |
10 Israel Human Insulin Drugs and Delivery Devices Market - Competitive Landscape |
10.1 Israel Human Insulin Drugs and Delivery Devices Market Revenue Share, By Companies, 2024 |
10.2 Israel Human Insulin Drugs and Delivery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |